Table 1 Baseline characteristics of patients according to RDW
Characteristics | RDW < 14.5% (n = 213) | RDW ≥ 14.5% (n = 69) | P ‡ |
|---|---|---|---|
Age, year | 63.7 ± 13.8 | 68.2 ± 13.1 | 0.018 |
Male gender, n (%) | 166 (77.9) | 43 (62.3) | 0.017 |
Diabetes mellitus, n (%) | 85 (39.9) | 35 (50.7) | 0.125 |
Hypertension, n (%) | 135 (63.4) | 43 (62.3) | 0.887 |
Old CVA, n (%) | 21 (9.9) | 5 (7.2) | 0.636 |
Smoker, n (%) | 80 (37.6) | 34 (49.3) | 0.092 |
Systolic BP, mmHg | 125.2 ± 25.6 | 129.0 ± 29.2 | 0.293 |
Diastolic BP, mmHg | 70.3 ± 15.6 | 66.2 ± 14.4 | 0.056 |
LVEF, % | 55.6 ± 15.7 | 48.4 ± 18.4 | 0.002 |
Lab data | |||
Leukocyte count, 1000/ml | 9.9 ± 3.3 | 9.6 ± 3.0 | 0.492 |
Hemoglobin, g/dl | 13.4 ± 2.3 | 11.3 ± 2.1 | <0.001 |
Platelet count, 1000/ml | 209.6 ± 60.3 | 207.3 ± 84.0 | 0.811 |
ALT, u/l | 40.5 ± 41.5 | 32.8 ± 44.0 | 0.185 |
Albumin, mg/dl | 3.8 ± 0.5 | 3.6 ± 0.5 | 0.005 |
Creatinine, mg/dl | 1.31 ± 0.93 | 1.89 ± 1.58 | <0.001 |
Na, mmol/L | 139.4 ± 3.3 | 138.8 ± 3.5 | 0.212 |
K, mmol/L | 3.9 ± 0.5 | 4.0 ± 0.5 | 0.416 |
Sugar, mg/dl | 162.6 ± 77.5 | 155.0 ± 73.0 | 0.477 |
Total cholesterol, mg/dL | 197.1 ± 37.5 | 198.9 ± 37.9 | 0.721 |
LDL, mg/dL | 109.5 ± 32.4 | 111.6 ± 31.3 | 0.649 |
HDL, mg/dL | 42.7 ± 12.7 | 46.1 ± 16.0 | 0.068 |
Medications, n (%) | |||
Anti-platelet agents | 207 (97.2) | 66 (95.7) | 0.461 |
Beta-blocker | 202 (94.8) | 63 (91.3) | 0.380 |
ACEi/ARB | 182 (85.4) | 54 (78.3) | 0.189 |
Statin | 196 (92.0) | 62 (89.9) | 0.621 |
Outcomes, n (%) | |||
Mortality | 8 (3.8) | 7 (10.1) | 0.059 |
Major composite CV outcome | 38 (17.8) | 32 (46.4) | <0.001 |